Can Biotech Crack the AMR Dilemma? Let’s Hope So
By Stephanie Vine
September 5, 2025
Rocket launcher antibiotics, subscription models, and articulating value; we discuss new progress in antimicrobial therapies with Michael Murray
9 min read
False
Advertisement
Small Molecules
Bringing Stability to APIs Under Stress
By Stephanie Vine
September 2, 2025
Researchers develop new tool for evaluating API stability under various conditions.
2 min read
Rethinking Weight Loss Treatments
August 29, 2025
“An entirely new category of weight loss drug.” MitoRx Therapeutics’ weight loss treatments with insulin sensitivity restoration.
2 min read
Chemistry and Crazy Ideas: Getting to Know Ali Tavassoli
August 27, 2025
Learning more about the people behind this year’s Power List: Ali Tavassoli, Chief Scientific Officer of Curve Therapeutics
10 min read
Mice Live Longer on Magic Mushrooms
August 22, 2025
Study supports systemic anti-aging potential of psilocybin
2 min read
Isotopic Fingerprints: A Forensic Frontier for Drug Product Authentication
August 18, 2025
Stable isotope ratio mass spectrometry used to assess drug authenticity and consistency.
3 min read
Shaping Drug Discovery with AI
August 15, 2025
A consortium of organizations is looking to set new precedents in compound discovery, validation, and clinical success for patients with delayed cerebral ischemia.
4 min read
Rewiring the Brain: A Dual-Drug Strategy to Tackle Alzheimer’s Disease
August 14, 2025
A tale of two cancer drugs: Study suggests that repurposing letrozole and irinotecan can restore memory and reverse pathology in Alzheimer’s model.
3 min read
Discovery Strategies for Oligonucleotides
By Stephanie Vine
August 14, 2025
Targeting disease at the genetic level isn’t science fiction – it’s oligonucleotides. Hilary Brooks reveals how smarter discovery strategies are reshaping what’s possible in drug development.
10 min read
Abivax on Phase III Strategy
August 12, 2025
As obefazimod reports positive phase III results, we discuss the strategic decisions that fueled rapid trial enrollment and how the groundwork is being laid for a potential market launch.
5 min read
